Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion type Assertion NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_head.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion description "[Thus CD44 may be a promising new epigenetic marker for diagnosis and a potential therapeutic target for the treatment of specific lymphoma subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_provenance.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion evidence source_evidence_literature NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_provenance.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion SIO_000772 20920234 NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_provenance.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion wasDerivedFrom befree-2016 NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_provenance.
- NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_assertion wasGeneratedBy ECO_0000203 NP843620.RAwYr00NVstMWRtvMqPUjQ_ZcoHbQrzJupQPUFY2KjrwA130_provenance.